Guidelines for the Diagnosis and Treatment ofHelicobacter pyloriInfection in Korea, 2013 Revised Edition
Open Access
- 1 January 2013
- journal article
- abstracts
- Published by The Korean Society of Gastroenterology in The Korean Journal of Gastroenterology
- Vol. 62 (1), 3-26
- https://doi.org/10.4166/kjg.2013.62.1.3
Abstract
Since the Korean College of Helicobacter and Upper Gastrointestinal Research has first developed the guideline for the diagnosis and treatment of Helicobacter pylori infection in 1998, the revised guideline was proposed in 2009 by the same group. Although the revised guideline was made by comprehensive review of previous articles and consensus of authoritative expert opinions, the evidence-based developmental process was not applied in the revision of the guideline. This new guideline has been revised especially in terms of changes in the indication and treatment of H. pylori infection in Korea, and developed by the adaptation process as evidence-based method; 6 guidelines were retrieved by systematic review and the Appraisal of Guidelines for Research and Evaluation (AGREE) II process, 21 statements were made with grading system and revised by modified Delphi method. After revision, 11 statements for the indication of test and treatment, 4 statements for the diagnosis and 4 statements for the treatment have been developed, respectively. The revised guideline has been reviewed by external experts before the official endorsement, and will be disseminated for usual clinical practice in Korea. Also, the scheduled update and revision of the guideline will be made periodically.Keywords
This publication has 142 references indexed in Scilit:
- Long‐term Follow‐up Helicobacter Pylori Reinfection Rate and Its Associated Factors in KoreaHelicobacter, 2012
- Inflammatory Markers Are Associated With Risk of Colorectal Cancer and Chemopreventive Response to Anti-Inflammatory DrugsGastroenterology, 2011
- Stomach Cancer Risk in Gastric Cancer RelativesJournal of Clinical Gastroenterology, 2010
- Bismuth‐Containing Quadruple Therapy as Second‐Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in KoreaHelicobacter, 2010
- Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trialThe Lancet, 2008
- Grading quality of evidence and strength of recommendations for diagnostic tests and strategiesBMJ, 2008
- A nested case–control study of the association of Helicobacter pylori infection with gastric adenocarcinoma in KoreaBritish Journal of Cancer, 2005
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infectionThe Lancet, 1995
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993